==== Front
JIMD Rep
JIMD Rep
10.1002/(ISSN)2192-8312
JMD2
JIMD Reports
2192-8304
2192-8312
John Wiley & Sons, Inc. Hoboken, USA

10.1002/jmd2.12376
JMD212376
Corrigendum
Corrigendum
CORRIGENDUM
02 7 2023
7 2023
02 7 2023
64 4 10.1002/jmd2.v64.4 300300
05 6 2023
© 2023 The Authors. JIMD Reports published by John Wiley & Sons Ltd on behalf of SSIEM.
https://creativecommons.org/licenses/by/4.0/ This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

10.1002/jmd2.12343 source-schema-version-number2.0
cover-dateJuly 2023
details-of-publishers-convertorConverter:WILEY_ML3GV2_TO_JATSPMC version:6.3.0 mode:remove_FC converted:02.07.2023
==== Body
pmcIn the following article, 1 there were errors in Figure 3 and Supplementary Figure 2. In both figures, the “Strongly Disagree / Disagree” and “Agree / Strongly Agree” results were transposed. Both figures have been corrected.

FIGURE 3  

The correct Figure 3 is shown below:

The Supplementary Figure 2 has been corrected online.

The authors apologize for the errors.
==== Refs
REFERENCE

1 Dickey A , Wheeden K , Lyon D , et al. Quantifying the impact of symptomatic acute hepatic porphyria on well‐being via patient‐reported outcomes: results from the Porphyria Worldwide Patient Experience Research (POWER) study. JIMD Rep. 2023;64 (1 ):104‐113.36636593